Pay in 4 interest-free payments of $7.42 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Compared with saline, DREADD-based activation of LS GLP-1R neurons via CNO reduced a 2-hour consumption period of both standard chow and high-sucrose food during the dark period when mice normally consume food actively (Figure 5, C and D)
Consult your physician before starting any peptide therapy program
Arch Neurol 46: 1121-1123 Malaguarnera M, Cammalleri L, Gargante MP, Vacante M, Colonna V, et al
These advancements position microneedle technology as a transformative approach for delivering GLP-1 receptor agonists, offering the potential to improve therapeutic adherence, minimize systemic side effects, and support decentralized care models for diabetes management [43]
